Skip to main content

Table 1 Summary of episodes with phenotypic changes

From: Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia

Patient code

Type of isolate

Collection interval (days)

Context of paired isolate

Days of treatment

Principal antibiotic

mecA

Van MIC (μg/ml)

Median doubling time

Mutations (SNP/indels)

Non-silent mutations

Small-colony variant and vancomycin MIC increase

 P_03

Index

–

–

–

–

Pos

0.75

34.5

–

0

 P_03

Paired invasive

38

Relapse (after treatment)

14

Van

Pos

2

53.9

4 (1/3)

4

 P_05

Index

–

–

–

–

Neg

1.5

38.4

–

0

 P_05

Paired invasive

18

Relapse (after treatment)

12

Flx

Neg

2

50.6

1 (1/0)

1

 P_30

Index

–

–

–

–

Pos

1.5

42.1

–

0

 P_30

Paired invasive

14

Persistent

14

Van

Pos

2

83.5

2 (1/1)

2

Vancomycin MIC increase

 P_42

Index

–

–

–

–

Pos

2

44.7

–

0

 P_42

Paired invasive

9

Persistent

8

Van

Pos

3

46.5

0 (0/0)

0

 P_46

Index

–

–

–

–

Pos

2

50.6

–

0

 P_46

Paired invasive

23

Relapse (on treatment)

21

Van

Pos

3

48.9

0 (0/0)

0

  1. Van vancomycin, Flx flucloxacillin, MIC minimum inhibitory concentration, SNP single nucleotide polymorphism